Tags

Type your tag names separated by a space and hit enter

[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
Nihon Rinsho. 2003 Nov; 61(11):1975-9.NR

Abstract

Neuraminidase inhibitor has changed the treatment of influenza dramatically. The drug is effective for both influenza A and B whereas amantadine, another anti-influenzal agent, inhibits influenza A virus infection but not B. Neuraminidase inhibitor blocks the process of release of influenza virus from infected cells and inhibit the virus transmission to the neighboring cells. Neuraminidase inhibitor improves the symptoms of influenza and shortens the duration of illness. It is emphasized that this drug should be given within forty-eight hours after the onset, and it must be not noted that the possibility of the drug resistant virus although it is observed infrequently. Prophylactic use of the drug is also discussed.

Authors+Show Affiliations

Department of Internal Medicine, Kurume University Medical Center.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

14619441

Citation

Kaji, Masahide. "[Neuraminidase Inhibitor, Anti-influenzal Agent--mechanism of Action, and How to Use Clinically]." Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 61, no. 11, 2003, pp. 1975-9.
Kaji M. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]. Nihon Rinsho. 2003;61(11):1975-9.
Kaji, M. (2003). [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 61(11), 1975-9.
Kaji M. [Neuraminidase Inhibitor, Anti-influenzal Agent--mechanism of Action, and How to Use Clinically]. Nihon Rinsho. 2003;61(11):1975-9. PubMed PMID: 14619441.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]. A1 - Kaji,Masahide, PY - 2003/11/19/pubmed PY - 2004/2/6/medline PY - 2003/11/19/entrez SP - 1975 EP - 9 JF - Nihon rinsho. Japanese journal of clinical medicine JO - Nihon Rinsho VL - 61 IS - 11 N2 - Neuraminidase inhibitor has changed the treatment of influenza dramatically. The drug is effective for both influenza A and B whereas amantadine, another anti-influenzal agent, inhibits influenza A virus infection but not B. Neuraminidase inhibitor blocks the process of release of influenza virus from infected cells and inhibit the virus transmission to the neighboring cells. Neuraminidase inhibitor improves the symptoms of influenza and shortens the duration of illness. It is emphasized that this drug should be given within forty-eight hours after the onset, and it must be not noted that the possibility of the drug resistant virus although it is observed infrequently. Prophylactic use of the drug is also discussed. SN - 0047-1852 UR - https://www.unboundmedicine.com/medline/citation/14619441/[Neuraminidase_inhibitor_anti_influenzal_agent__mechanism_of_action_and_how_to_use_clinically]_ L2 - https://medlineplus.gov/flu.html DB - PRIME DP - Unbound Medicine ER -